FLT1 and non-small cell lung carcinoma: Considering all these pieces of evidence supporting the role of the rs9582036 polymorphism in VEGFR-1 in treatment response and outcome in NSCLC, more studies are needed to understand the molecular mechanism of VEGFR-1 genetic variation in response to VEGF blockage.